FDA Approves Glycopyrrolate Oral Solution for Chronic Severe Drooling
The FDA has approved glycopyrrolate oral solution for the treatment of patients aged 3 to 16 years with chronic severe drooling associated with neurologic conditions, such as cerebral palsy.
Medscape Medical News
Daptomycin May Be Linked to Eosinophilic Pneumonia
In 7 cases reviewed by the FDA, patients developed eosinophilic pneumonia 2 to 4 weeks after starting daptomycin treatment.
Medscape Medical News
Exposure to Estradiol Transdermal Spray Risky for Children and Pets, FDA Says
The FDA urges healthcare professionals to advise their patients who spray the drug on their forearm to keep children and pets from coming into contact with the medicated area of skin.
Medscape Medical News
Aggressive Glucose Control in Patients With Diabetes and Kidney Disease Not Associated With Improved Survival
A study suggests that in the absence of randomized controlled trials, aggressive management of HbA1c levels in patients with diabetes and end-stage kidney failure is not warranted.
Medscape Medical News